APO Research
Talk to an analyst

APO RESEARCH · REPORT

COX-2 Selective NSAIDs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global COX-2 Selective NSAIDs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025188 pages

Choose your research edition.

Industry ResearchCOX-2 Selective NSAIDs Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal COX-2 Selective NSAIDs Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal COX-2 Selective NSAIDs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal COX-2 Selective NSAIDs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal COX-2 Selective NSAIDs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global COX-2 Selective NSAIDs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for COX-2 Selective NSAIDs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for COX-2 Selective NSAIDs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for COX-2 Selective NSAIDs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for COX-2 Selective NSAIDs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of COX-2 Selective NSAIDs include Teva, Merck, Mylan, Jiangsu Hengrui Medicine, Pfizer, Lupin and Apotex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global COX-2 Selective NSAIDs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of COX-2 Selective NSAIDs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents COX-2 Selective NSAIDs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the COX-2 Selective NSAIDs market size, projected growth trends, production technologies, key applications, and end-use industries.

COX-2 Selective NSAIDs Segment by Company

Teva

Merck

Mylan

Jiangsu Hengrui Medicine

Pfizer

Lupin

Apotex

COX-2 Selective NSAIDs Segment by Type

Valdecoxib

Rofecoxib

Celecoxib

Etoricoxib

COX-2 Selective NSAIDs Segment by Application

Hospital

Clinic

Other

COX-2 Selective NSAIDs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global COX-2 Selective NSAIDs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of COX-2 Selective NSAIDs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of COX-2 Selective NSAIDs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the COX-2 Selective NSAIDs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of COX-2 Selective NSAIDs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of COX-2 Selective NSAIDs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of COX-2 Selective NSAIDs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. COX-2 Selective NSAIDs Industry Trends Table 2. COX-2 Selective NSAIDs Industry Drivers Table 3. COX-2 Selective NSAIDs Industry Opportunities and Challenges Table 4. COX-2 Selective NSAIDs Industry Restraints Table 5. Global COX-2 Selective NSAIDs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global COX-2 Selective NSAIDs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global COX-2 Selective NSAIDs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global COX-2 Selective NSAIDs Sales Market Share by Manufacturers Table 9. Global COX-2 Selective NSAIDs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global COX-2 Selective NSAIDs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global COX-2 Selective NSAIDs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global COX-2 Selective NSAIDs Manufacturers, Product Type & Application Table 13. Global COX-2 Selective NSAIDs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global COX-2 Selective NSAIDs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Valdecoxib Table 17. Major Manufacturers of Rofecoxib Table 18. Major Manufacturers of Celecoxib Table 19. Major Manufacturers of Etoricoxib Table 20. Global COX-2 Selective NSAIDs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units) Table 22. Global COX-2 Selective NSAIDs Sales by Type (2027-2032) & (K Units) Table 23. Global COX-2 Selective NSAIDs Sales Market Share by Type (2021-2026) Table 24. Global COX-2 Selective NSAIDs Sales Market Share by Type (2027-2032) Table 25. Global COX-2 Selective NSAIDs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global COX-2 Selective NSAIDs Revenue by Type (2021-2026) & (K Units) Table 27. Global COX-2 Selective NSAIDs Revenue by Type (2027-2032) & (K Units) Table 28. Global COX-2 Selective NSAIDs Revenue Market Share by Type (2021-2026) Table 29. Global COX-2 Selective NSAIDs Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Other Table 33. Global COX-2 Selective NSAIDs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units) Table 35. Global COX-2 Selective NSAIDs Sales by Application (2027-2032) & (K Units) Table 36. Global COX-2 Selective NSAIDs Sales Market Share by Application (2021-2026) Table 37. Global COX-2 Selective NSAIDs Sales Market Share by Application (2027-2032) Table 38. Global COX-2 Selective NSAIDs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global COX-2 Selective NSAIDs Revenue by Application (2021-2026) & (K Units) Table 40. Global COX-2 Selective NSAIDs Revenue by Application (2027-2032) & (K Units) Table 41. Global COX-2 Selective NSAIDs Revenue Market Share by Application (2021-2026) Table 42. Global COX-2 Selective NSAIDs Revenue Market Share by Application (2027-2032) Table 43. Global COX-2 Selective NSAIDs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global COX-2 Selective NSAIDs Sales by Region (2021-2026) & (K Units) Table 45. Global COX-2 Selective NSAIDs Sales Market Share by Region (2021-2026) Table 46. Global COX-2 Selective NSAIDs Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global COX-2 Selective NSAIDs Sales Forecasted Market Share by Region (2027-2032) Table 48. North America COX-2 Selective NSAIDs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America COX-2 Selective NSAIDs Sales by Country (2021-2026) & (K Units) Table 50. North America COX-2 Selective NSAIDs Sales by Country (2027-2032) & (K Units) Table 51. Europe COX-2 Selective NSAIDs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe COX-2 Selective NSAIDs Sales by Country (2021-2026) & (K Units) Table 53. Europe COX-2 Selective NSAIDs Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific COX-2 Selective NSAIDs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific COX-2 Selective NSAIDs Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific COX-2 Selective NSAIDs Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa COX-2 Selective NSAIDs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa COX-2 Selective NSAIDs Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa COX-2 Selective NSAIDs Sales by Country (2027-2032) & (K Units) Table 60. Global COX-2 Selective NSAIDs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global COX-2 Selective NSAIDs Revenue by Region (2021-2026) & (US$ Million) Table 62. Global COX-2 Selective NSAIDs Revenue by Region (2027-2032) & (US$ Million) Table 63. Global COX-2 Selective NSAIDs Revenue Market Share by Region (2021-2026) Table 64. Global COX-2 Selective NSAIDs Revenue Market Share by Region (2027-2032) Table 65. Teva Company Information Table 66. Teva Business Overview Table 67. Teva COX-2 Selective NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Teva COX-2 Selective NSAIDs Product Portfolio Table 69. Teva Recent Development Table 70. Merck Company Information Table 71. Merck Business Overview Table 72. Merck COX-2 Selective NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Merck COX-2 Selective NSAIDs Product Portfolio Table 74. Merck Recent Development Table 75. Mylan Company Information Table 76. Mylan Business Overview Table 77. Mylan COX-2 Selective NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Mylan COX-2 Selective NSAIDs Product Portfolio Table 79. Mylan Recent Development Table 80. Jiangsu Hengrui Medicine Company Information Table 81. Jiangsu Hengrui Medicine Business Overview Table 82. Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Product Portfolio Table 84. Jiangsu Hengrui Medicine Recent Development Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer COX-2 Selective NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Pfizer COX-2 Selective NSAIDs Product Portfolio Table 89. Pfizer Recent Development Table 90. Lupin Company Information Table 91. Lupin Business Overview Table 92. Lupin COX-2 Selective NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Lupin COX-2 Selective NSAIDs Product Portfolio Table 94. Lupin Recent Development Table 95. Apotex Company Information Table 96. Apotex Business Overview Table 97. Apotex COX-2 Selective NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Apotex COX-2 Selective NSAIDs Product Portfolio Table 99. Apotex Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. COX-2 Selective NSAIDs Distributors List Table 103. COX-2 Selective NSAIDs Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. COX-2 Selective NSAIDs Product Image Figure 2. Global COX-2 Selective NSAIDs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global COX-2 Selective NSAIDs Market Size (2021-2032) & (US$ Million) Figure 4. Global COX-2 Selective NSAIDs Sales (2021-2032) & (K Units) Figure 5. Global COX-2 Selective NSAIDs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 COX-2 Selective NSAIDs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Valdecoxib Image Figure 9. Rofecoxib Image Figure 10. Celecoxib Image Figure 11. Etoricoxib Image Figure 12. Global COX-2 Selective NSAIDs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global COX-2 Selective NSAIDs Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global COX-2 Selective NSAIDs Sales Market Share by Type (2021-2032) Figure 15. Global COX-2 Selective NSAIDs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global COX-2 Selective NSAIDs Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global COX-2 Selective NSAIDs Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Other Image Figure 21. Global COX-2 Selective NSAIDs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global COX-2 Selective NSAIDs Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global COX-2 Selective NSAIDs Sales Market Share by Application (2021-2032) Figure 24. Global COX-2 Selective NSAIDs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global COX-2 Selective NSAIDs Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global COX-2 Selective NSAIDs Revenue Market Share by Application (2021-2032) Figure 27. North America COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America COX-2 Selective NSAIDs Sales Market Share by Country (2021-2032) Figure 29. U.S. COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe COX-2 Selective NSAIDs Sales Market Share by Country (2021-2032) Figure 34. Germany COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific COX-2 Selective NSAIDs Sales Market Share by Country (2021-2032) Figure 41. China COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa COX-2 Selective NSAIDs Sales Market Share by Country (2021-2032) Figure 49. Brazil COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile COX-2 Selective NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global COX-2 Selective NSAIDs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global COX-2 Selective NSAIDs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Figure 60. North America COX-2 Selective NSAIDs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Figure 62. Europe COX-2 Selective NSAIDs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific COX-2 Selective NSAIDs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa COX-2 Selective NSAIDs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. COX-2 Selective NSAIDs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. COX-2 Selective NSAIDs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Valdecoxib
  • Rofecoxib
  • Celecoxib
  • Etoricoxib
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Teva
  • Merck
  • Mylan
  • Jiangsu Hengrui Medicine
  • Pfizer
  • Lupin
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global COX-2 Selective NSAIDs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global COX-2 Selective NSAIDs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global COX-2 Selective NSAIDs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global COX-2 Selective NSAIDs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global COX-2 Selective NSAIDs Market Dynamics
  1. 2.1 COX-2 Selective NSAIDs Industry Trends
  2. 2.2 COX-2 Selective NSAIDs Industry Drivers
  3. 2.3 COX-2 Selective NSAIDs Industry Opportunities and Challenges
  4. 2.4 COX-2 Selective NSAIDs Industry Restraints
3 COX-2 Selective NSAIDs Market by Manufacturers
  1. 3.1 Global COX-2 Selective NSAIDs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global COX-2 Selective NSAIDs Sales by Manufacturers (2021-2026)
  3. 3.3 Global COX-2 Selective NSAIDs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global COX-2 Selective NSAIDs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global COX-2 Selective NSAIDs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global COX-2 Selective NSAIDs Manufacturers, Product Type & Application
  7. 3.7 Global COX-2 Selective NSAIDs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global COX-2 Selective NSAIDs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 COX-2 Selective NSAIDs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 COX-2 Selective NSAIDs Tier 1, Tier 2, and Tier 3
4 COX-2 Selective NSAIDs Market by Type
  1. 4.1 COX-2 Selective NSAIDs Type Introduction
  2. 4.1.1 Valdecoxib
  3. 4.1.2 Rofecoxib
  4. 4.1.3 Celecoxib
  5. 4.1.4 Etoricoxib
  6. 4.2 Global COX-2 Selective NSAIDs Sales by Type
  7. 4.2.1 Global COX-2 Selective NSAIDs Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global COX-2 Selective NSAIDs Sales by Type (2021-2032)
  9. 4.2.3 Global COX-2 Selective NSAIDs Sales Market Share by Type (2021-2032)
  10. 4.3 Global COX-2 Selective NSAIDs Revenue by Type
  11. 4.3.1 Global COX-2 Selective NSAIDs Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global COX-2 Selective NSAIDs Revenue by Type (2021-2032)
  13. 4.3.3 Global COX-2 Selective NSAIDs Revenue Market Share by Type (2021-2032)
5 COX-2 Selective NSAIDs Market by Application
  1. 5.1 COX-2 Selective NSAIDs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global COX-2 Selective NSAIDs Sales by Application
  6. 5.2.1 Global COX-2 Selective NSAIDs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global COX-2 Selective NSAIDs Sales by Application (2021-2032)
  8. 5.2.3 Global COX-2 Selective NSAIDs Sales Market Share by Application (2021-2032)
  9. 5.3 Global COX-2 Selective NSAIDs Revenue by Application
  10. 5.3.1 Global COX-2 Selective NSAIDs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global COX-2 Selective NSAIDs Revenue by Application (2021-2032)
  12. 5.3.3 Global COX-2 Selective NSAIDs Revenue Market Share by Application (2021-2032)
6 Global COX-2 Selective NSAIDs Sales by Region
  1. 6.1 Global COX-2 Selective NSAIDs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global COX-2 Selective NSAIDs Sales by Region (2021-2032)
  3. 6.2.1 Global COX-2 Selective NSAIDs Sales by Region (2021-2026)
  4. 6.2.2 Global COX-2 Selective NSAIDs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America COX-2 Selective NSAIDs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America COX-2 Selective NSAIDs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe COX-2 Selective NSAIDs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe COX-2 Selective NSAIDs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific COX-2 Selective NSAIDs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific COX-2 Selective NSAIDs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa COX-2 Selective NSAIDs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa COX-2 Selective NSAIDs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global COX-2 Selective NSAIDs Revenue by Region
  1. 7.1 Global COX-2 Selective NSAIDs Revenue by Region
  2. 7.1.1 Global COX-2 Selective NSAIDs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global COX-2 Selective NSAIDs Revenue by Region (2021-2026)
  4. 7.1.3 Global COX-2 Selective NSAIDs Revenue by Region (2027-2032)
  5. 7.1.4 Global COX-2 Selective NSAIDs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America COX-2 Selective NSAIDs Revenue (2021-2032)
  8. 7.2.2 North America COX-2 Selective NSAIDs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe COX-2 Selective NSAIDs Revenue (2021-2032)
  11. 7.3.2 Europe COX-2 Selective NSAIDs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific COX-2 Selective NSAIDs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific COX-2 Selective NSAIDs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa COX-2 Selective NSAIDs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa COX-2 Selective NSAIDs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva COX-2 Selective NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva COX-2 Selective NSAIDs Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck COX-2 Selective NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck COX-2 Selective NSAIDs Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan COX-2 Selective NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mylan COX-2 Selective NSAIDs Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Jiangsu Hengrui Medicine
  20. 8.4.1 Jiangsu Hengrui Medicine Company Information
  21. 8.4.2 Jiangsu Hengrui Medicine Business Overview
  22. 8.4.3 Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Product Portfolio
  24. 8.4.5 Jiangsu Hengrui Medicine Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer COX-2 Selective NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer COX-2 Selective NSAIDs Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Lupin
  32. 8.6.1 Lupin Company Information
  33. 8.6.2 Lupin Business Overview
  34. 8.6.3 Lupin COX-2 Selective NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lupin COX-2 Selective NSAIDs Product Portfolio
  36. 8.6.5 Lupin Recent Developments
  37. 8.7 Apotex
  38. 8.7.1 Apotex Company Information
  39. 8.7.2 Apotex Business Overview
  40. 8.7.3 Apotex COX-2 Selective NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Apotex COX-2 Selective NSAIDs Product Portfolio
  42. 8.7.5 Apotex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 COX-2 Selective NSAIDs Value Chain Analysis
  2. 9.1.1 COX-2 Selective NSAIDs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 COX-2 Selective NSAIDs Production Mode & Process
  6. 9.2 COX-2 Selective NSAIDs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 COX-2 Selective NSAIDs Distributors
  9. 9.2.3 COX-2 Selective NSAIDs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst